Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS)

(2)
Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS) image
ISBN-10:

0071446745

ISBN-13:

9780071446747

Edition: 13
Released: Oct 05, 2005
Format: Paperback, 384 pages
Related ISBN: 9780838563427

Description:

This review guide is the fastest way to review and master every major area of pharmacy when preparing for the NAPLEX exam. Invaluable to the 8,000+ pharmacy students who annually take the NAPLEX, this book/CD-ROM package is also useful for course and final exam review.

Best prices to buy, sell, or rent ISBN 9780071446747




Frequently Asked Questions about Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS)

You can buy the Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $6.99 on Amazon and is available from 7 sellers at the moment.

If you’re interested in selling back the Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS) book, the best buyback offer comes from and is $ for the book in good condition.

The Quick Review: Pharmacy, Thirteenth Edition (APPLETON & LANGE'S QUICK REVIEW PHARMACY: QUESTIONS & ANSWERS) book is in very low demand now as the rank for the book is 4,794,399 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.